Distinct GAB2 signaling pathways are essential for myeloid and lymphoid transformation and leukemogenesis by BCR-ABL1

Tyrosine kinase inhibitors (TKIs) directed against BCR-ABL1, the product of the Philadelphia (Ph) chromosome, have revolutionized treatment of patients with chronic myeloid leukemia (CML). However, acquired resistance to TKIs is a significant clinical problem in CML, and TKI therapy is much less eff...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Blood
Autori principali: Gu, Shengqing, Chan, Wayne W., Mohi, Golam, Rosenbaum, Joel, Sayad, Azin, Lu, Zhibin, Virtanen, Carl, Li, Shaoguang, Neel, Benjamin G., Van Etten, Richard A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Hematology 2016
Soggetti:
Myeloid Neoplasia
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4825414/
https://ncbi.nlm.nih.gov/pubmed/26773044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-06-653006
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi